Beilstein J. Org. Chem. 2012, 8, 1725–1729.
using silica-gel column chromatography (mobile phase 2–5% orated under vacuum. The crude product was obtained and puri-
ethyl acetate in pet. ether). 4-Pentenals 3a–h were obtained in fied by silica-gel column chromatography (mobile phase 2–3%
83–89% yield.
ethyl acetate in petroleum ether). The products 6a–h were
obtained in 84–87% yield.
General procedure for the protection of aldehyde
Aldehydes 3a–h obtained from Claisen rearrangement
(15 mmol) were dissolved in anhydrous toluene (25 mL). To
this solution, a catalytic amount of p-TSA (1.5 mmol, 0.1 equiv)
and ethylene glycol (45 mmol, 3 equiv) were added. The reac-
tion mixture was heated under reflux for 3–4 h by using a
Dean–Stark condenser (TLC, ethyl acetate/petroleum ether 1:9).
After removal of the solvent under reduced pressure, water
(20 mL) was added to the reaction mixture, and then the
aqueous layer was extracted with ethyl acetate (3 × 15 mL), the
combined organic layer was dried over sodium sulfate, and
ethyl acetate was evaporated under vacuum. Finally, the prod-
uct was purified by silica-gel column chromatography (mobile
phase 1–3% ethyl acetate in petroleum ether). The products
4a–h were obtained in 89–93% yield.
Supporting Information
Supporting Information File 1
IR, 1H NMR, 13C NMR and CHN analysis and spectral
data of synthesized compounds.
The geometric isomeric ratios for 2g and 2h and
diastereomeric ratios for 3a–h, 4a–h and 5a–h were
calculated from their NMR signals.
Acknowledgements
MPD would like to thank UGC, New Delhi and DRB, YBS, and
RG would like to thank CSIR, New Delhi for the fellowship.
General procedure for the oxidative cleavage of
alkene
References
1. Gross, W.; Oberkobusch, D.; Höffkes, H.; Moch, M. Hair Colourants.
Alkenes 4a–h (13.5 mmol), obtained as described above, were
dissolved in aq. THF (30 mL, THF/H2O 1:1). N-Methylmor-
pholine-N-oxide (NMO) (27 mmol, 2 equiv) and potassium
osmate (0.027 mmol, 2 mol %) were added to this solution. The
mixture was stirred at room temperature for 2–3 h until the
starting compound disappeared (TLC, ethyl acetate/petroleum
ether 1:9). Then, sodium metaperiodate was added (27 mmol,
2 equiv) and stirring was continued for 1 h (TLC, ethyl acetate/
petroleum ether 1:9). THF was removed under reduced pres-
sure. Water (20 mL) was added to the reaction mixture, and
then the aqueous layer was extracted with ethyl acetate
(3 × 10 mL), the combined organic layer was dried over sodium
sulfate, and ethyl acetate was evaporated under vacuum. The
crude product was obtained after removal of the solvent under
reduced pressure. The product was purified by using silica-gel
column chromatography (mobile phase 4–7% ethyl acetate in
petroleum ether). The products 5a–h were obtained in 89–95%
yield.
W.O. Patent 2007/073923, July 5, 2007.
2. Allen, D. R.; Buckley, G. M.; Bürli, R.; Davenport, R. J.; Kinsella, N.;
Lock, C. J.; Lowe, C.; Mack, S. R.; Pitt, W. R.; Ratcliffe, A. J.;
Richard, M. D.; Savin, V. M.; Sharpe, A.; Tait, L. J.; Warrelow, G. J.;
Williams, S. C. Quinoxaline and Quinoline Derivatives as Kinase
Inhibitors. W.O. Patent 2009/081105, July 2, 2009.
3. Schmitt, M.; Klotz, E.; Macher, J.-P.; Bourguignon, J.-J. Compositions
Derived from Quinoline and Quinoxaline, Preparation and Use Thereof.
W.O. Patent 2003/010146, Feb 6, 2003.
4. Chujo, I.; Masuda, Y.; Fujino, K.; Kato, S.; Ogasa, T.; Mohri, S.-i.;
Kasai, M. Bioorg. Med. Chem. 2001, 9, 3273–3286.
5. Cappelli, A.; Anzini, M.; Vomero, S.; Mennuni, L.; Markovec, F.;
Doucet, E.; Hamon, M.; Menziani, M. C.; De Benedetti, P. G.;
Giorgi, G.; Ghelardini, C.; Collina, S. Bioorg. Med. Chem. 2002, 10,
6. Sliskovic, D. R.; Picard, J. A.; Roark, W. H.; Roth, B. D.; Ferguson, E.;
Krause, B. R.; Newton, R. S.; Sekerke, C.; Shaw, M. K. J. Med. Chem.
7. Campiani, G.; Fattorusso, C.; Butini, S.; Gaeta, A.; Agnusdei, M.;
Gemma, S.; Persico, M.; Catalanotti, B.; Savini, L.; Nacci, V.;
Novellino, E.; Holloway, H. W.; Greig, N. H.; Belinskaya, T.;
Fedorko, J. M.; Saxena, A. J. Med. Chem. 2005, 48, 1919–1929.
General procedure for the reductive cyclization
Aldehydes 5a–h (11 mmol) were dissolved in glacial acetic acid
(20 mL) and heated under reflux with zinc dust (5 equiv) for
0.5 h (TLC, ethyl acetate/petroleum ether 1:9). Acetic acid was
evaporated under vacuum, and chloroform was added to the
residue. The solution was filtered through a celite bed. CHCl3
was removed under reduced pressure. Water (25 mL) was added
to the reaction mixture, and then the aqueous layer was
extracted with ethyl acetate (3 × 15 mL), the combined organic
layer was dried over sodium sulfate, and ethyl acetate was evap-
8. Lyakhova, E. A.; Lyakhov, S. A.; Litvinova, L. A.; Andronati, S. A.;
Lebedyuk, M. N.; Fedchuk, V. P.; Khorokhorina, G. A. Pharm. Chem. J.
9. Chupak, L. S.; Flanagan, M. E.; Kaneko, T.; Magee, T. V.; Noe, M. C.;
Reilly, U. Macrolides. U.S. Patent 2006/0135447, June 22, 2006.
10.Da Rocha Pitta, I.; Alves De Lima, M. d. C.; Lins Galdino, S.; Barbe, J.
Molecules with Antitumor Activity and Chemical Synthesis. W.O. Patent
2004/024058, March 25, 2004.
1728